ImaginAb, Agency for Science, Technology and Research deal

ImaginAb and A*STAR partnered to reengineer an antibody against protein tyrosine phosphatase type IVA 3 ( PTP4A3; PRL3) into an imaging agent to study the biology of the target in humans. Further te...